Arrhythmia Patterns in Patients on Ibrutinib

Arrhythmia Patterns in Patients on Ibrutinib

Introduction: Ibrutinib, a Bruton's tyrosine kinase inhibitor (TKI) used primarily in the treatment of hematologic malignancies, has been associated with increased incidence of atrial fibrillation (AF), with limited data on its association with other tachyarrhythmias. There are limited reports...

Full description

Bibliographic Details
Main Authors: Muhammad Fazal, Ridhima Kapoor, Paul Cheng, Albert J. Rogers, Sanjiv M. Narayan, Paul Wang, Ronald M. Witteles, Alexander C. Perino, Tina Baykaner, June-Wha Rhee
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
cardio-oncology
tyrosine kinase inhibitor
atrial fibrillation
ventricular arrhythmia
ibrutinib
ambulatory event monitor
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.792310/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2021.792310/full

Similar Items